Caveolins and macrophage lipid metabolism

Journal of Lipid Research

Volumn 44, Issue 1, 2003, Pages 11-21

  Gargalovic, Peter ^a   Dory, Ladislav ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Cholesterol transport; Lipid rafts; Membranes

Indexed keywords

CAVEOLIN; LIPID;

ADIPOCYTE; ATHEROSCLEROSIS; CAVEOLA; CELL METABOLISM; CHOLESTEROL TRANSPORT; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; LIPID MEMBRANE; LIPID METABOLISM; MACROPHAGE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; CAVEOLINS; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; MACROPHAGES;

EID: 0037243138     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R200005-JLR200     Document Type: Review

References (109)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362: 801-809.
2. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
3. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261.
4. von Eckardstein, A., J. R. Nofer, and G. Assmann. 2001. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21: 13-27.
5. Glomset, J. A. 1968. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
6. Fielding, C. J., and P. E. Fielding. 2001. Caveolae and intracellular trafficking of cholesterol. Adv. Drug Deliv. Rev. 49: 251-264.
7. Anderson, R. G. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225.
8. Glenney, J. R., Jr. 1989. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J. Biol. Chem. 264: 20163-20166.
9. Glenney, J. R., Jr., and L. Zokas. 1989. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108: 2401-2408.
10. Engelman, J. A., X. Zhang, F. Galbiati, D. Volonte, F. Sotgia, R. G. Pestell, C. Minetti, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1998. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am. J. Hum. Genet. 63: 1578-1587.
11. Scherer, P. E., R. Y. Lewis, D. Volonte, J. A. Engelman, F. Galbiati, J. Couet, D. S. Kohtz, E. van Donselaar, P. Peters, and M. P. Lisanti. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272: 29337-29346.
12. Tang, Z., P. E. Scherer, T. Okamoto, K. Song, C. Chu, D. S. Kohtz, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271: 2255-2261.
13. Glenney, J. R., Jr. 1992. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett. 314: 45-48.
14. Glenney, J. R., Jr., and D. Soppet. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA. 89: 10517-10521.
15. Dietzen, D. J., W. R. Hastings, and D. M. Lublin. 1995. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 270: 6838-6842.
16. Dupree, P., R. G. Parton, G. Raposo, T. V. Kurzchalia, and K. Simons. 1993. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12: 1597-1605.
17. Schlegel, A., and M. P. Lisanti. 2000. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J. Biol. Chem. 275: 21605-21617.
18. Schlegel, A., R. B. Schwab, P. E. Scherer, and M. P. Lisanti. 1999. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J. Biol. Chem. 274: 22660-22667.
19. Luetterforst, R., E. Stang, N. Zorzi, A. Carozzi, M. Way, and R. G. Parton. 1999. Molecular characterization of caveolin association with the Golgi complex: identification of a cis-Golgi targeting domain in the caveolin molecule. J. Cell Biol. 145: 1443-1459.
20. Machleidt, T., W. P. Li, P. Liu, and R. G. Anderson. 2000. Multiple domains in caveolin-1 control its intracellular traffic. J. Cell Biol. 148: 17-28.
21. Uittenbogaard, A., and E. J. Smart. 2000. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J. Biol. Chem. 275: 25595-25599.
22. Kurzchalia, T. V., P. Dupree, R. G. Parton, R. Kellner, H. Virta, M. Lehnert, and K. Simons. 1992. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118: 1003-1014.
23. Smart, E. J., Y. Ying, W. C. Donzell, and R. G. Anderson. 1996. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271: 29427-29435.
24. Conrad, P. A., E. J. Smart, Y. S. Ying, R. G. Anderson, and G. S. Bloom. 1995. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J. Cell Biol. 131: 1421-1433.
25. Liu, P., W. P. Li, T. Machleidt, and R. G. Anderson. 1999. Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells. Nat. Cell Biol. 1: 369-375.
26. Sargiacomo, M., P. E. Scherer, Z. Tang, E. Kubler, K. S. Song, M. C. Sanders, and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA. 92: 9407-9411.
27. Monier, S., D. J. Dietzen, W. R. Hastings, D. M. Lublin, and T. V. Kurzchalia. 1996. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388: 143-149.
28. Monier, S., R. G. Parton, F. Vogel, J. Behlke, A. Henske, and T. V. Kurzchalia. 1995. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell. 6: 911-927.
29. Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. S. Ying, J. R. Glenney, and R. G. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell. 68: 673-682.
30. Razani, B., J. A. Engelman, X. B. Wang, W. Schubert, X. L. Zhang, C. B. Marks, F. Macaluso, R. G. Russell, M. Li, R. G. Pestell, D. Di Vizio, H. Hou, Jr., B. Kneitz, G. Lagaud, G. J. Christ, W. Edelmann, and M. P. Lisanti. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276: 38121-38138.
31. Drab, M., P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F. C. Luft, A. Schedl, H. Haller, and T. V. Kurzchalia. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 293: 2449-2452.
32. Li, S., K. S. Song, S. S. Koh, A. Kikuchi, and M. P. Lisanti. 1996. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis. J. Biol. Chem. 271: 28647-28654.
33. Fielding, C. J., and P. E. Fielding. 1997. Intracellular cholesterol transport. J. Lipid Res. 38: 1503-1521.
34. Chun, M., U. K. Liyanage, M. P. Lisanti, and H. F. Lodish. 1994. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA. 91: 11728-11732.
35. Toya, Y., C. Schwencke, J. Couet, M. P. Lisanti, and Y. Ishikawa. 1998. Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology. 139: 2025-2031.
36. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273: 5419-5422.
37. Schlegel, A., and M. P. Lisanti. 2001. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev. 12: 41-51.
38. Li, S., F. Galbiati, D. Volonte, M. Sargiacomo, J. A. Engelman, K. Das, P. E. Scherer, and M. P. Lisanti. 1998. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett. 434: 127-134.
39. Mora, R., V. L. Bonilha, A. Marmorstein, P. E. Scherer, D. Brown, M. P. Lisanti, and E. Rodriguez-Boulan. 1999. Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1. J. Biol. Chem. 274: 25708-25717.
40. Parolini, I., M. Sargiacomo, F. Galbiati, G. Rizzo, F. Grignani, J. A. Engelman, T. Okamoto, T. Ikezu, P. E. Scherer, R. Mora, E. Rodriguez-Boulan, C. Peschle, and M. P. Lisanti. 1999. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J. Biol. Chem. 274: 25718-25725.
41. Gargalovic, P., and L. Dory. 2001. Caveolin-1 and caveolin-2 expression in mouse macrophages. High density lipoprotein 3-stimulated secretion and a lack of significant subcellular co-localization. J. Biol. Chem. 276: 26164-26170.
42. Fujimoto, T., H. Kogo, K. Ishiguro, K. Tauchi, and R. Nomura. 2001. Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J. Cell Biol. 152: 1079-1085.
43. Galbiati, F., J. A. Engelman, D. Volonte, X. L. Zhang, C. Minetti, M. Li, H. Hou, Jr., B. Kneitz, W. Edelmann, and M. P. Lisanti. 2001. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem. 276: 21425-21433.
44. Minetti, C., F. Sotgia, C. Bruno, P. Scartezzini, P. Broda, M. Bado, E. Masetti, M. Mazzocco, A. Egeo, M. A. Donati, D. Volonte, F. Galbiati, G. Cordone, F. D. Bricarelli, M. P. Lisanti, and F. Zara. 1998. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18: 365-368.
45. Galbiati, F., D. Volonte, J. B. Chu, M. Li, S. W. Fine, M. Fu, J. Bermudez, M. Pedemonte, K. M. Weidenheim, R. G. Pestell, C. Minetti, and M. P. Lisanti. 2000. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc. Natl. Acad. Sci. USA. 97: 9689-9694.
46. Galbiati, F., B. Razani, and M. P. Lisanti. 2001. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol. Med. 7: 435-441.
47. Baorto, D. M., Z. Gao, R. Malaviya, M. L. Dustin, A. van der Merwe, D. M. Lublin, and S. N. Abraham. 1997. Survival of FimHexpressing enterobacteria in macrophages relies on glycolipid traffic. Nature. 389: 636-639.
48. Lei, M. G., and D. C. Morrison. 2000. Differential expression of caveolin-1 in lipopolysaccharide-activated murine macrophages. Infect. Immun. 68: 5084-5089.
49. Kiss, A. L., A. Turi, N. Mullner, and J. Timar. 2000. Caveolin isoforms in resident and elicited rat peritoneal macrophages. Eur. J. Cell Biol. 79: 343-349.
50. Kiss, A. L., A. Turi, N. Muller, O. Kantor, and E. Botos. 2002. Caveolae and caveolin isoforms in rat peritoneal macrophages. Micron. 33: 75-93.
51. Sakr, S. W., D. L. Williams, G. W. Stoudt, M. C. Phillips, and G. H. Rothblat. 1999. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim. Biophys. Acta. 1438: 85-98.
52. Arakawa, R., S. Abe-Dohmae, M. Asai, J. I. Ito, and S. Yokoyama. 2000. Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. J. Lipid Res. 41: 1952-1962.
53. Avart, S. J., D. W. Bernard, W. G. Jerome, and J. M. Glick. 1999. Cholesteryl ester hydrolysis in J774 macrophages occurs in the cytoplasm and lysosomes. J. Lipid Res. 40: 405-414.
54. Smith, J. D., M. Miyata, M. Ginsberg, C. Grigaux, E. Shmookler, and A. S. Plump. 1996. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271: 30647-30655.
55. Matveev, S., D. R. van der Westhuyzen, and E. J. Smart. 1999. Coexpression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J. Lipid Res. 40: 1647-1654.
56. Fra, A. M., E. Williamson, K. Simons, and R. G. Parton. 1995. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. USA. 92: 8655-8659.
57. Murata, M., J. Peranen, R. Schreiner, F. Wieland, T. V. Kurzchalia, and K. Simons. 1995. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA. 92: 10339-10343.
58. Trigatti, B. L., R. G. Anderson, and G. E. Gerber. 1999. Identification of caveolin-1 as a fatty acid binding protein. Biochem. Biophys. Res. Commun. 255: 34-39.
59. Smart, E. J., Y. S. Ying, P. A. Conrad, and R. G. Anderson. 1994. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J. Cell Biol. 127: 1185-1197.
60. Ridgway, N. D., P. A. Dawson, Y. K. Ho, M. S. Brown, and J. L. Goldstein. 1992. Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. J. Cell Biol. 116: 307-319.
61. Uittenbogaard, A., Y. Ying, and E. J. Smart. 1998. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J. Biol. Chem. 273: 6525-6532.
62. Li, S., K. S. Song, and M. P. Lisanti. 1996. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem. 271: 568-573.
63. Fielding, C. J., A. Bist, and P. E. Fielding. 1997. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc. Natl. Acad. Sci. USA. 94: 3753-3758.
64. Hailstones, D., L. S. Sleet, R. G. Parton, and K. K. Stanley. 1998. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J. Lipid Res. 39: 369-379.
65. Bist, A., P. E. Fielding, and C. J. Fielding. 1997. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl. Acad. Sci. USA. 94: 10693-10698.
66. Czarny, M., G. Fiucci, Y. Lavie, Y. Banno, Y Nozawa, and M. Liscovitch. 2000. Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains. FEBS Lett. 467: 326-332.
67. Bist, A., C. J. Fielding, and P. E. Fielding. 2000. p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry. 39: 1966-1972.
68. Parish, E. J., S. C. Parish, and S. Li. 1995. Side-chain oxysterol regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Lipids. 30: 247-251.
69. Wang, X., R. Sato, M. S. Brown, X. Hua, and J. L. Goldstein. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77: 53-62.
70. Graf, G. A., S. V. Matveev, and E. J. Smart. 1999. Class B scavenger receptors, caveolae and cholesterol homeostasis. Trends Cardiovasc. Med. 9: 221-225.
71. Lisanti, M. P., P. E. Scherer, J. Vidugiriene, Z. Tang, A. Hermanowski-Vosatka, Y. H. Tu, R. F. Cook, and M. Sargiacomo. 1994. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126: 111-126.
72. Babitt, J., B. Trigatti, A. Rigotti, E. J. Smart, R. G. Anderson, S. Xu, and M. Krieger. 1997. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272: 13242-13249.
73. Dorahy, D. J., L. F. Lincz, C. J. Meldrum, and G. F. Burns. 1996. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochem. J. 319: 67-72.
74. Connelly, M. A., S. M. Klein, S. Azhar, N. A. Abumrad, and D. L. Williams. 1999. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 274: 41-47.
75. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
76. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
77. Gu, X., K. Kozarsky, and M. Krieger. 2000. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275: 29993-30001.
78. Jian, B., M. de la Llera-Moya, Y. Ji, N. Wang, M. C. Phillips, J. B. Swaney, A. R. Tall, and G. H. Rothblat. 1998. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J. Biol. Chem. 273: 5599-5606.
79. Matveev, S., A. Uittenbogaard, D. van Der Westhuyzen, and E. J. Smart. 2001. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur. J. Biochem. 268: 5609-5616.
80. Huh, H. Y., S. F. Pearce, L. M. Yesner, J. L. Schindler, and R. L. Silverstein. 1996. Regulated expression of CD36 during monocyteto-macrophage differentiation: potential role of CD36 in foam cell formation. Blood. 87: 2020-2028.
81. Ho, Y. K., M. S. Brown, and J. L. Goldstein. 1980. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J. Lipid Res. 21: 391-398.
82. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages. Formation of high density lipoproteinlike lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
83. Dory, L. 1989. Synthesis and secretion of apoE in thioglycolateelicited mouse peritoneal macrophages: effect of cholesterol efflux. J. Lipid Res. 30: 809-816.
84. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
85. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
86. Miller, N. E., D. S. Thelle, O. H. Forde, and O. D. Mjos. 1977. The Tromso heart-study. High-density lipoprotein and coronary, heart-disease: a prospective case-control study. Lancet. 1: 965-968.
87. Wilson, P. W., K. M. Anderson, T. Harris, W. B. Kannel, and W. P. Castelli. 1994. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J. Gerontol. 49: M252-257.
88. Yu, J., D. A. Fischman, and T. L. Steck. 1973. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J. Supramol. Struct. 1: 233-248.
89. Schroeder, R., E. London, and D. Brown. 1994. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc. Natl. Acad. Sci. USA. 91: 12130-12134.
90. Rietveld, A., and K. Simons. 1998. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta. 1376: 467-479.
91. Remaley, A. T., B. D. Farsi, A. C. Shirali, J. M. Hoeg, and H. B. Brewel, Jr. 1998. Differential rate of cholesterol efflux from the apical and basolateral membranes of MDCK cells. J. Lipid Res. 39: 1231-1238.
92. Scheiffele, P., A. Rietveld, T. Wilk, and K. Simons. 1999. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274: 2038-2044.
93. Mendez, A. J., G. Lin, D. P. Wade, R. M. Lawn, and J. F. Oram. 2001. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretony pathway. J. Biol. Chem. 276: 3158-3166.
94. Fielding, C. J., and P. E. Fielding. 2001. Cellular cholesterol efflux. Biochim. Biophys. Acta. 1533: 175-189.
95. Fielding, C. J., A. Bist, and P. E. Fielding. 1999. Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry. 38: 2506-2513.
96. Frank, P. G., F. Galbiati, D. Volonte, B. Razani, D. E. Cohen, Y. L. Marcel, and M. P. Lisanti. 2001. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am. J. Physiol. Cell Physiol. 280: C1204-1214.
97. Dolo, V., R. Li, M. Dillinger, S. Flati, J. Manela, B. J. Taylor, A. Pavan, and S. Ladisch. 2000. Enrichment and localization of ganglioside G(D3) and caveolin-1 in shed tumor cell membrane vesicles. Biochim. Biophys. Acta. 1486: 265-274.
98. Black, P. H. 1980. Shedding from the cell surface of normal and cancer cells. Adv. Cancer Res. 32: 75-199.
99. Bobryshev, Y. V., R. S. Lord, N. K. Golovanova, E. V. Gracheva, N. D. Zvezdina, and N. V. Prokazova. 2001. Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation. Biochim. Biophys. Acta. 1535: 87-99.
100. Langmann, T., J. Klucken, M. Reil, G. Liebisch, M. F. Luciani, G. Chimini, W. E. Kaminski, and G. Schmitz. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257: 29-33.
101. Alam, R., F. M. Yatsu, L. Tsui, and S. Alam. 1989. Receptor-mediated uptake and 'retroendocytosis' of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport. Biochim. Biophys. Acta. 1004: 292-299.
102. Takahashi, K., S. Fukuda, M. Naito, S. Horiuchi, K. Takata, and Y. Morino. 1989. Endocytic pathway of high density lipoprotein via trans-Golgi system in rat resident peritoneal macrophages. Lab. Invest. 61: 270-277.
103. Schmitz, G., H. Robenek, U. Lohmann, and G. Assmann. 1985. Interaction of high density lipoproteins with cholesteryl esterladen macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J. 4: 613-622.
104. Takahashi, Y., and J. D. Smith. 1999. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calciumdependent pathway. Proc. Natl. Acad. Sci. USA. 96: 11358-11363.
105. Dory, L. 1991. Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages. J. Lipid Res. 32: 783-792.
106. Bortnick, A. E., G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone. 2000. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634-28640.
107. Goldberg, D. I., and J. C. Khoo. 1990. Stimulation of a neutral cholesteryl ester hydrolase by cAMP system in P388D1 macrophages. Biochim. Biophys. Acta. 1042: 132-137.
108. Roy, S., R. Luetterforst, A. Harding, A. Apolloni, M. Etheridge, E. Stang, B. Rolls, J. F. Hancock, and R. G. Parton. 1999. Dominantnegative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell Biol. 1: 98-105.
109. Hegyi, L., S. J. Hardwick, R. C. Siow, and J. N. Skepper. 2001. Macrophage death and the role of apoptosis in human atherosclerosis. J. Hematother. Stem Cell Res. 10: 27-42.